VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 47 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $4,000 | -88.2% | 857 | -78.5% | 0.00% | – |
Q4 2020 | $34,000 | +142.9% | 3,981 | +203.0% | 0.00% | – |
Q3 2020 | $14,000 | -99.6% | 1,314 | -99.5% | 0.00% | -100.0% |
Q2 2020 | $3,419,000 | +139.9% | 256,410 | +56.6% | 0.00% | +50.0% |
Q1 2020 | $1,425,000 | -39.5% | 163,765 | -3.1% | 0.00% | 0.0% |
Q4 2019 | $2,357,000 | +4108.9% | 168,928 | +5117.0% | 0.00% | – |
Q3 2019 | $56,000 | -26.3% | 3,238 | +15.2% | 0.00% | – |
Q2 2019 | $76,000 | +406.7% | 2,811 | +244.1% | 0.00% | – |
Q1 2019 | $15,000 | +275.0% | 817 | +95.0% | 0.00% | – |
Q4 2018 | $4,000 | -83.3% | 419 | -66.9% | 0.00% | – |
Q3 2018 | $24,000 | -4.0% | 1,265 | -0.3% | 0.00% | – |
Q2 2018 | $25,000 | -21.9% | 1,269 | -26.1% | 0.00% | – |
Q1 2018 | $32,000 | +113.3% | 1,717 | +87.2% | 0.00% | – |
Q4 2017 | $15,000 | +650.0% | 917 | +683.8% | 0.00% | – |
Q3 2017 | $2,000 | -99.4% | 117 | -99.6% | 0.00% | – |
Q4 2016 | $340,000 | +325.0% | 27,293 | +306.3% | 0.00% | – |
Q3 2016 | $80,000 | +42.9% | 6,718 | +32.8% | 0.00% | – |
Q2 2016 | $56,000 | – | 5,060 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |